Amyloid precursor protein 17-mer peptide ameliorates hippocampal neurodegeneration in ovariectomized rats

Neuroscience Letters

Volumn 468, Issue 3, 2010, Pages 173-177

  Meng, Yan ^a   Wang, Rong ^a   Yang, Fang ^a   Ji, Zhi juan ^a   Fang, Li ^b   Sheng, Shu li ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

APP 17 mer peptide; Neurodegeneration; Ovariectomy

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN 17 MER PEPTIDE; ESTRADIOL; ESTROGEN; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENT; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; HIPPOCAMPUS; LEARNING; MEMORY; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; ESTRADIOL; ESTROGENS; FEMALE; HIPPOCAMPUS; MAZE LEARNING; NERVE DEGENERATION; NERVE GROWTH FACTORS; NEURONS; OVARIECTOMY; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR;

EID: 72549101530     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.07.058     Document Type: Article

References (23)

1. Almeida O.P., and Flicker L. Association between hormone replacement therapy and dementia: is it time to forget?. Int. Psychogeriatr. 17 (2005) 155-164 (Review)
2. Brinton R.D. Impact of estrogen therapy on Alzheimer's disease: a fork in the road?. CNS Drugs. 18 (2004) 405-422 (Review)
3. Cardona-Gomez G.P., DonCarlos L., and Garcia-Segura L.M. Insulin-like growth factor I receptors and estrogen receptors colocalize in female rat brain. Neuroscience 99 (2000) 751-760
4. Cellek S., Foxwell N.A., and Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 52 (2003) 2353-2362
5. Cho J.J., Iannucci F.A., Fraile M., Franco J., Alesius T.N., and Stefano G.B. The role of the estrogen in neuroprotection: implications for neurodegenerative diseases. Neuro. Endocrinol. Lett. 24 (2003) 141-147 (Review)
6. Dubal D.B., Kashon M.L., Pettigrew L.C., Ren J.M., Finklestein S.P., Rau S.W., and Wise P.M. Estradiol protects against ischemic injury. J. Cereb. Blood. Flow. Metab. 18 (1998) 1253-1258
7. Gandy S. Estrogen neurodegeneration. Neurochem. Res. 28 (2003) 1003-1008 (Review)
8. Garcia-Segura L.M., Cardona-Gomez G.P., Chowen J.A., and Azcoitia I. Insulin-like growth factor-I receptors and estrogen receptors interact in the promotion of neuronal survival and neuroprotection. J. Neurocytol. 29 (2000) 425-437 (Review)
9. Garcia-Segura L.M., Azcoitia I., and DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63 (2001) 29-60 (Review)
10. Green P.S., and Simpkins J.W. Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci. 18 (2000) 347-358 (Review)
11. Henderson V.W., and Buckwalter J.G. Cognitive deficits of men and women with Alzheimer's disease. Neurology 44 (1994) 90-96
12. Johansson I.M., Birzniece V., Lindblad C., Olsson T., and Bäckström T. Allopregnanolone inhibits learning in the Morris water maze. Brain Res. 934 (2002) 125-131
13. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D.D., and Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48 (1997) 1517-1521
14. Mendez P., Azcoitia I., and Garcia-Segura L.M. Interdependence of oestrogen and insulin-like growth factor-I in the brain: potential for analyzing neuroprotective mechanisms. J. Endocrinol. 185 (2005) 11-17 (Review)
15. Molto L., Rayman P., Paszkiewicz-Kozik E., Thornton M., Resse L., Thomas J.C., Das T., Kudo D., Bukowski R., Finke J., and Tannenbaum C. The Bcl-2 transgene protects T cells from renal cell carcinoma-mediated apoptosis. Clin. Cancer Res. 9 (2003) 4060-4068
16. Paganini-Hill A., and Henderson V.W. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140 (1994) 256-261
17. Patrone C., Ma Z.Q., Pollio G., Agrati P., Parker M.G., and Maggi A. Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Mol. Endocrinol. 10 (1996) 499-507
18. Roch J.M., Masliah E., Roch-Levecq A.C., Sundsmo M.P., Otero D.A., Veinbergs I., and Saitoh T. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 7450-7454
19. Shuli S., Yongmei Z., Zhiwei Z., and Zhijuan J. beta-Amyloid and its binding protein in the hippocampus of diabetic mice: effect of APP17 peptide. Neuroreport 12 (2001) 3317-3319
20. Wang R., Zhang J.Y., Yang F., Ji Z.J., Chakraborty G., and Sheng S.L. A novel neurotrophic peptide: APP63-73. Neuroreport 15 (2004) 2677-2680
21. Yaffe K., Sawaya G., Lieberburg I., and Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279 (1998) 688-695
22. Zhao Y.M., Pei J.J., Ji Z.J., Zhao Z.W., Qian Y.Y., and Sheng S.L. Effect of amyloid precursor protein 17mer peptide on microtubule structure and tau protein hyperphosphorylation in hippocampal neurons of experimental diabetic mice. Neuroreport 14 (2003) 61-66
23. Zhuang X.M., Zhao Z.W., Ji Z.J., Zhao Y.M., and Sheng S.L. Effect of APP17 peptide on the hippocampal neurons ultrastructure and expression of InsR, Ins21 in Type 2 diabetic KKAy mice. J. Capital Univer. Med. Sci. 23 (2002) 115-118 (in Chinese)